Biology of Aging

Adult stem cells, or somatic stem cells, are undifferentiated cells residing in specific tissue niches that maintain and repair the tissue throughout life. Examples include hematopoietic, mesenchymal, intestinal, and neural stem cells. They are typically multipotent, generating the cell types of their tissue of origin. Their decline with age underlies stem cell exhaustion, making their preservation and rejuvenation a primary goal of longevity and regenerative medicine.

Advanced glycation end-products are stable, often crosslinked compounds formed when sugars react with proteins, lipids, or DNA over time. They accumulate in long-lived tissues such as skin, cartilage, and arterial walls, where they impair elasticity and function. AGEs activate the RAGE receptor, triggering inflammation and oxidative stress. Their build-up is linked to diabetes complications, atherosclerosis, kidney disease, and skin ageing.

AMPK (AMP-activated protein kinase) is a cellular energy sensor activated when AMP and/or ADP relative to ATP rise, signaling low energy availability. Once active, it stimulates catabolic pathways like fatty acid oxidation and autophagy while inhibiting anabolic processes such as mTORC1-driven protein synthesis. AMPK activation mimics aspects of caloric restriction, and age-related changes in AMPK signaling can contribute to impaired metabolic regulation. Metformin and exercise are well-known indirect AMPK activators.

Apoptosis is a tightly regulated form of programmed cell death in which cells are dismantled in an orderly fashion via caspase activation, typically without triggering inflammation as it is non-lytic and anti-inflammatory relative to necrosis or pyroptosis. It eliminates damaged, infected, or surplus cells and is essential for development, tissue homeostasis, and tumor suppression. Tissue- and context-specific changes in apoptosis with age contribute to impaired clearance of damaged or senescent cells in some tissues and to atrophy and neurodegeneration in others.

Autophagy is a conserved lysosomal degradation pathway in which cells engulf damaged organelles, misfolded proteins, and other cytoplasmic material in double-membrane vesicles called autophagosomes for recycling (a process most precisely describing macroautophagy, the dominant subtype). By clearing dysfunctional components and recycling amino acids during nutrient stress, it maintains cellular homeostasis. Declining autophagic flux is widely observed with age, though the magnitude is tissue- and context-dependent, and its induction by fasting, exercise, and rapamycin is considered one of the major proposed longevity mechanisms.

Cellular reprogramming is the experimental conversion of one cell type into another, most often a differentiated somatic cell into a pluripotent stem cell, by forcing expression of specific transcription factors such as OSKM. The process resets the epigenome, including DNA methylation and histone marks, effectively reversing many molecular age signatures. It underpins iPSC technology and is being explored as a route to organ regeneration and systemic rejuvenation.

Cellular senescence is a stable cell-cycle arrest triggered by stressors such as DNA damage, telomere dysfunction, oncogene activation or oxidative stress. Senescent cells remain metabolically active and typically secrete a pro-inflammatory mixture of cytokines, chemokines and proteases known as the SASP. While senescence initially suppresses tumour formation and aids wound healing, the accumulation of senescent cells with age contributes to tissue dysfunction and age-related disease.

Chromatin is the complex of DNA, histones, and associated proteins that packages the genome inside the nucleus. Its basic unit, the nucleosome, can be tightly compacted as heterochromatin or loosely arranged as euchromatin, controlling which genes are accessible for transcription. Chromatin organisation safeguards genomic stability and cellular identity. Loss of heterochromatin and disorganised chromatin architecture are recognised hallmarks of ageing and contribute to cellular dysfunction.

DNA damage refers to chemical or structural alterations of the genome, including base modifications, single- and double-strand breaks, and crosslinks. It arises from reactive oxygen species, ionising radiation, UV light, and replication stress. Cells respond through DNA damage repair pathways; when overwhelmed, damage triggers senescence, apoptosis, or mutations. Genomic instability driven by accumulated DNA damage is a recognised hallmark of ageing and a cancer driver.

DNA methylation is an epigenetic modification in which methyl groups are added to cytosine bases, predominantly at CpG sites, by DNA methyltransferases. It regulates gene expression, X-inactivation, and genome stability without altering the underlying sequence. Methylation patterns shift predictably with age, forming the basis of epigenetic clocks such as Horvath's. Aberrant methylation contributes to cancer, immune dysfunction, and the broader epigenetic drift seen in ageing.

Epigenetic alterations are age-related changes in DNA methylation patterns, histone modifications, chromatin architecture and non-coding RNA expression that occur without changes to the underlying DNA sequence. With age, the epigenome typically shows global hypomethylation alongside focal hypermethylation, loss of heterochromatin and altered transcription. These shifts underpin epigenetic clocks such as the Horvath and GrimAge clocks, which estimate biological age and predict mortality more accurately than chronological age.

FOXO transcription factors (Forkhead box O) are downstream effectors of the insulin/IGF-1 pathway that regulate genes governing stress resistance, DNA repair, autophagy, and antioxidant defense. When insulin/IGF-1 signaling is low, FOXO enters the nucleus and activates protective transcriptional programs. FOXO3 variants are among the most reproducibly associated genetic markers of human exceptional longevity, observed across centenarian cohorts in multiple ethnicities.

Free radicals are atoms or molecules carrying one or more unpaired electrons, which makes them highly reactive. They arise from normal metabolism, immune activity, and external sources such as UV radiation, pollution, and tobacco smoke. By stealing electrons from neighbouring molecules, free radicals damage membranes, enzymes, and DNA. The free-radical theory of ageing posits that this cumulative damage contributes to functional decline and age-related disease.

Genomic instability is the progressive accumulation of damage to nuclear and mitochondrial DNA, including point mutations, chromosomal rearrangements, copy-number changes and retrotransposon activation. It arises from endogenous sources such as replication errors and reactive oxygen species as well as exogenous insults like UV light and toxins, and is exacerbated by declining DNA-repair capacity. As one of the primary hallmarks of ageing, it drives clonal expansion, cancer risk and tissue dysfunction.

Glycation is the non-enzymatic attachment of sugars such as glucose or fructose to proteins, lipids, or nucleic acids. Through the Maillard reaction it generates unstable Schiff bases, then Amadori products, and ultimately advanced glycation end-products. Glycation stiffens collagen, impairs enzyme activity, and disrupts cell signalling. Driven primarily by hyperglycaemia and elevated glycaemic load, it accelerates skin ageing, vascular stiffening, and diabetic complications.

The Hallmarks of Aging are a set of interconnected biological processes proposed by López-Otín and colleagues to describe the molecular and cellular drivers of ageing. The 2023 update lists twelve hallmarks, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, disabled macroautophagy, chronic inflammation and dysbiosis. They serve as the dominant framework for longevity research and intervention design.

The Hayflick limit is the maximum number of times a normal human somatic cell can divide in culture, typically 40 to 60 times, before entering replicative senescence. Discovered by Leonard Hayflick in 1961, the limit is mechanistically explained by progressive telomere shortening with each division. It established that aging has a cell-intrinsic component and remains a foundational concept linking cellular replication, telomere biology, and organismal aging.

Heat shock proteins (HSPs) are a family of highly conserved molecular chaperones, named for their induction by heat but active under many forms of stress. They assist protein folding, prevent aggregation, attempt to refold denatured proteins when possible, and route irreparable ones for degradation. HSPs such as HSP70 and HSP90 are central to proteostasis, and HSP induction by exercise and heat exposure (including sauna) is studied as one contributing mechanism among many for their health effects.

Histone modifications are reversible chemical changes to histone proteins around which DNA is wound, including acetylation, methylation, phosphorylation, and ubiquitination. They reshape chromatin structure and recruit regulatory complexes, thereby controlling gene transcription, DNA repair, and replication. The combined pattern is often called the histone code. Age-related shifts in histone marks contribute to epigenetic drift, loss of cellular identity, and dysregulated stress and longevity pathways.

Hormesis is a biphasic dose-response phenomenon in which a low or moderate dose of a stressor produces a beneficial adaptive effect, while higher doses are harmful. Mild stressors such as heat, cold, exercise, fasting, or certain phytochemicals can involve activation of defence and adaptive pathways such as Nrf2, heat-shock proteins and AMPK in some settings, with the precise response depending on dose, tissue and context. In longevity research, hormesis is one mechanistic framework, alongside others, for why intermittent stress can extend healthspan in model organisms.

IGF-1 signaling refers to the cascade triggered when insulin-like growth factor 1 binds the IGF-1 receptor, activating parallel PI3K/AKT and MAPK/ERK branches that promote cell growth, proliferation, and protein synthesis while suppressing FOXO-driven stress resistance. IGF-1 can also engage insulin/IGF-1R hybrid receptors at lower affinity. Reduced IGF-1 signaling extends lifespan in worms, flies, and mice, and lower circulating IGF-1 is observed in some long-lived human cohorts. The trade-off between growth/repair benefits and longevity costs remains actively debated.

Inflammaging describes the chronic, low-grade, sterile inflammation that develops with age in the absence of overt infection. It is characterised by often elevated baseline levels of pro-inflammatory mediators such as IL-6, TNF-alpha and CRP, driven by senescent cells, accumulated cellular debris, gut dysbiosis and immune dysregulation. Inflammaging is a recognised hallmark of ageing and, in many studies, an independent risk factor associated with increased risk of cardiovascular disease, neurodegeneration, frailty, sarcopenia and overall mortality.

The insulin/IGF-1 pathway (often abbreviated IIS) is a conserved nutrient-sensing network in which insulin and IGF-1 bind tyrosine kinase receptors to activate PI3K, AKT, and mTOR while inhibiting FOXO. It coordinates glucose uptake, growth, and anabolic metabolism with nutrient availability. Loss-of-function mutations along this pathway dramatically extend lifespan in C. elegans (daf-2), Drosophila, and mice, establishing IIS as a foundational longevity pathway across the animal kingdom.

Induced pluripotent stem cells (iPSCs) are adult somatic cells reprogrammed into a pluripotent state using factors such as OSKM, capable of differentiating into any cell type of the body. They bypass the ethical concerns of embryonic stem cells and enable patient-specific disease modeling, drug screening, and autologous cell therapies. In aging research, iPSCs reset many epigenetic age markers, providing a powerful platform to study and reverse cellular aging.

Klotho (here referring to alpha-Klotho, distinct from beta-Klotho) is a transmembrane protein, predominantly expressed in the kidney and brain, that also circulates as a soluble hormone after cleavage. It regulates phosphate and vitamin D homeostasis via FGF23 co-receptor function and modulates several signaling pathways including insulin/IGF-1, Wnt, and others. Klotho-deficient mice show accelerated aging phenotypes, while Klotho overexpression extends lifespan. Higher circulating Klotho levels in humans are associated with better cognitive performance and reduced cardiovascular and renal disease risk.

Loss of proteostasis is one of the established hallmarks of aging and describes the age-related decline of the protein quality control network. Chaperones become less efficient, the proteasome and autophagy slow down, and misfolded or aggregation-prone proteins accumulate. The resulting proteotoxicity contributes to neurodegenerative disorders, cardiac amyloidosis, and cellular dysfunction across tissues, making proteostasis enhancers an active longevity research target.

The lysosome is a membrane-bound organelle filled with acidic hydrolases that degrade proteins, lipids, nucleic acids, and carbohydrates delivered via endocytosis, phagocytosis, or autophagy. Beyond digestion, it acts as a metabolic and signaling hub that senses nutrients through the mTORC1 pathway. Lysosomal dysfunction underlies storage diseases and contributes to aging by impairing autophagy, clearance of lipofuscin, and overall cellular waste management.

Mitochondrial biogenesis is the process by which cells increase mitochondrial mass and capacity by coordinating the expression of nuclear and mitochondrial genes. The transcriptional coactivator PGC-1-alpha is a key nodal regulator, regulated by AMPK and SIRT1 among other signals. Endurance exercise, caloric restriction, and cold exposure are well-established physiological stimuli, and robust biogenesis is associated with muscular endurance, metabolic flexibility, and healthy aging.

Mitochondrial dysfunction refers to a decline in mitochondrial efficiency, including reduced ATP output, impaired electron transport chain activity, increased reactive oxygen species, and altered mitochondrial dynamics. It is recognized as a hallmark of aging and is implicated in sarcopenia, type 2 diabetes, neurodegeneration, and cardiovascular disease. Interventions under study include exercise, NAD+ precursors, urolithin A, and senolytics, while extreme antioxidant supplementation has not shown longevity benefit.

Mitophagy is the selective form of autophagy that targets damaged or depolarized mitochondria for lysosomal degradation, with the PINK1/Parkin pathway being the best-characterized route alongside PINK1/Parkin-independent receptor pathways. By removing dysfunctional mitochondria, it can help limit oxidative stress and support bioenergetic function. Impaired mitophagy is linked to neurodegeneration, sarcopenia, and cardiovascular aging, and compounds such as urolithin A are studied for effects consistent with enhanced mitophagy markers, including in older and middle-aged adults.

mTOR (mechanistic target of rapamycin) is a serine/threonine kinase that integrates signals from amino acids, growth factors, and cellular energy status to regulate protein synthesis, cell growth, and autophagy. It functions in two complexes, mTORC1 and mTORC2. Chronic mTORC1 hyperactivation accelerates aging phenotypes, while pharmacologic inhibition with rapamycin extends lifespan in multiple model organisms, making mTOR one of the most validated longevity targets.

NAD+ (nicotinamide adenine dinucleotide, oxidized form) is a coenzyme central to redox reactions in energy metabolism and a required substrate for sirtuins, PARPs, and CD38. Cellular NAD+ levels decline substantially with age across tissues, impairing mitochondrial function, DNA repair, and sirtuin activity. NAD+ precursors such as NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are studied as supplements aimed at restoring tissue NAD+, with mixed clinical evidence.

NADH is the reduced form of NAD+, generated when NAD+ accepts electrons during glycolysis, the citric acid cycle, and fatty acid oxidation. It delivers electrons to the mitochondrial electron transport chain, driving ATP synthesis. The cellular NAD+/NADH ratio reflects metabolic state and influences sirtuin activity, redox signaling, and substrate selection. A shifted ratio toward NADH, often observed in aging and metabolic disease, is associated with reductive stress and mitochondrial dysfunction.

Oxidative stress is an imbalance between reactive oxygen species production and the body's antioxidant defences, leading to oxidative damage of biomolecules. It impairs mitochondrial function, accelerates telomere attrition, and drives chronic low-grade inflammation. Implicated in many hallmarks of ageing, oxidative stress is associated with cardiovascular disease, neurodegeneration, diabetes, and cancer, and is modulated by diet, exercise, sleep, and environmental exposures.

p16INK4a is a cyclin-dependent kinase inhibitor encoded by the CDKN2A locus that blocks CDK4/6, halting cell cycle progression and enforcing cellular senescence. Its expression rises markedly with chronological age across many tissues, making it a widely used biomarker of senescent cell burden and biological aging. Selective elimination of p16-positive senescent cells (senolysis) extends healthspan in mice, motivating ongoing senolytic drug development for age-related disease.

Partial reprogramming uses transient or low-dose expression of Yamanaka factors to rejuvenate cells without erasing their differentiated identity or inducing pluripotency. Studies in mice show restoration of youthful epigenetic patterns, improved tissue regeneration, and extended healthspan. Because full reprogramming risks teratoma formation, partial protocols aim to capture rejuvenation benefits while preserving cell function. It is an active and contested frontier in longevity research, with safety and durability still under investigation.

Protein crosslinks are covalent bonds that join two protein molecules or different segments of the same protein. They can form enzymatically, as with collagen maturation, or non-enzymatically through oxidation and glycation by sugars and reactive aldehydes. Pathological crosslinks accumulate in long-lived structural proteins like collagen, elastin, and crystallins, stiffening tissues. This contributes to vascular rigidity, skin ageing, cataracts, and reduced organ elasticity.

Proteostasis, short for protein homeostasis, is the integrated network that controls protein synthesis, folding, trafficking, and degradation to keep the proteome functional. Key players include ribosomes, molecular chaperones, the ubiquitin-proteasome system, and autophagy-lysosome pathways. Maintaining proteostasis is essential for cellular function; its progressive failure with age underlies neurodegenerative diseases such as Alzheimer's and Parkinson's and is recognized as a hallmark of aging.

Reactive oxygen species are oxygen-containing molecules such as superoxide, hydrogen peroxide, and hydroxyl radicals produced by multiple cellular sources, including mitochondrial respiration, NADPH oxidases, peroxisomes, and the immune respiratory burst. At low levels they act as signalling molecules regulating immunity and metabolism, but excess ROS damages lipids, proteins, and DNA. Chronic ROS accumulation contributes to mitochondrial decline, cellular senescence, and age-related diseases including cardiovascular and neurodegenerative disorders.

Regenerative medicine is the field developing therapies to repair, replace, or regenerate damaged cells, tissues, and organs. Approaches include stem cell transplantation, tissue engineering, gene therapy, organoids, biomaterial scaffolds, and cellular reprogramming. By restoring lost function rather than only managing symptoms, it aims to address age-related degeneration, organ failure, and chronic disease. It is closely intertwined with longevity science, where reversing cellular and tissue aging is a central therapeutic objective.

The senescence-associated secretory phenotype, or SASP, is the complex mixture of cytokines, chemokines, growth factors, proteases and extracellular vesicles released by senescent cells. It is regulated by multiple pathways, prominently including NF-kB, with mTOR, cGAS-STING, p38 MAPK and C/EBPbeta also influencing SASP output in certain contexts. Depending on context, the SASP can recruit immune cells to clear damaged tissue or, when persistent, fuel chronic low-grade inflammation, fibrosis and paracrine senescence in neighbouring cells, making it a key mechanistic link between cellular senescence and age-related disease.

Senolytics are compounds that selectively induce cell death in senescent cells by exploiting context-specific survival vulnerabilities, including BCL-2 family proteins, PI3K/AKT signalling and disruption of pro-survival complexes such as the FOXO4-p53 interaction. The vulnerabilities targeted are heterogeneous and compound-specific. Studied candidates include the dasatinib plus quercetin combination, fisetin and navitoclax. In animal models, intermittent senolytic dosing improves physical function and extends healthspan, but human evidence is still limited to early-phase trials and clinical use outside studies is not established.

Senomorphics, also called senostatics, are compounds that suppress the harmful secretory activity of senescent cells without killing them. They typically target signalling pathways that drive the SASP, including NF-kB, mTOR, JAK/STAT and p38 MAPK. Examples studied preclinically include rapamycin, metformin, ruxolitinib and certain flavonoids. The aim is to reduce chronic inflammation and tissue damage from senescent cells while preserving any beneficial roles they may have in wound healing and tumour suppression.

Sirtuins are a family of seven NAD+-dependent enzymes (SIRT1–SIRT7) that deacetylate or otherwise modify proteins involved in metabolism, DNA repair, mitochondrial function, and stress response. Their activity depends on cellular NAD+ availability, linking nutrient status to gene regulation. Sirtuins are implicated in caloric restriction's longevity effects, though direct lifespan extension by sirtuin activators in mammals remains debated. SIRT1, SIRT3, and SIRT6 receive the most aging-related research attention.

Stem cell exhaustion is the age-related decline in the number, function, and regenerative capacity of tissue-resident stem cells. Drivers include accumulated DNA damage, telomere attrition, epigenetic drift, mitochondrial dysfunction, and a deteriorating niche environment. Consequences include impaired wound healing, anemia, immunosenescence, sarcopenia, and reduced tissue homeostasis. Recognized as a hallmark of aging, it is a key target for regenerative and reprogramming-based interventions.

Telomerase is a ribonucleoprotein reverse transcriptase (TERT plus the TERC RNA template) that adds TTAGGG repeats to chromosome ends, counteracting replicative shortening. It is highly active in germline, stem, and most cancer cells but largely silenced in adult somatic tissues. In longevity research, telomerase reactivation has extended healthspan in mice, but it carries oncogenic risk because most human tumors depend on telomerase for unlimited proliferation.

Telomeres are repetitive TTAGGG DNA sequences capping the ends of linear chromosomes, protecting them from degradation, fusion, and erroneous repair. Each somatic cell division shortens telomeres because DNA polymerase cannot fully replicate chromosome ends. Critically short telomeres trigger senescence or apoptosis. Telomere attrition is one of the twelve hallmarks of aging and is associated with cardiovascular disease, immune decline, and reduced regenerative capacity.

Telomere attrition is the progressive shortening of the protective TTAGGG repeat sequences at chromosome ends with each cell division, due to the end-replication problem and oxidative damage. Once telomeres reach a critical length, cells enter replicative senescence or apoptosis via a DNA-damage response. Telomerase, which can extend telomeres, is largely silenced in adult somatic cells. Accelerated attrition is associated with premature ageing syndromes, cardiovascular disease and reduced healthspan.

The ubiquitin-proteasome system (UPS) is a major route for selective degradation of short-lived, misfolded, or regulatory proteins, complementary to autophagy-lysosomal degradation. Target proteins are tagged with ubiquitin chains via E1 activating, E2 conjugating, and E3 ligase enzymes, with the E3 ligase providing substrate specificity; K48-linked polyubiquitin chains are the canonical proteasome-targeting signal, while other linkages have non-degradative roles. Tagged proteins are then unfolded and degraded into short peptides inside the 26S proteasome. UPS activity declines with age, contributing to loss of proteostasis and neurodegeneration.

The Yamanaka factors are four transcription factors, OCT4, SOX2, KLF4, and c-MYC (OSKM), identified by Shinya Yamanaka in 2006 as sufficient to reprogram differentiated somatic cells back into a pluripotent embryonic-like state. This discovery, awarded the 2012 Nobel Prize, demonstrated that cellular identity and aging are reversible. They are now central tools in regenerative medicine, disease modeling, and longevity research focused on epigenetic rejuvenation.